Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000791441 | SCV000290487 | pathogenic | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2024-01-21 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 934 of the KCNT1 protein (p.Ala934Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with early-onset epileptic encephalopathy, including malignant migrating partial seizures of infancy (PMID: 23086397, 25482562, 26122718, 26140313, 26993267). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 39594). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KCNT1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects KCNT1 function (PMID: 23086397, 24591078). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV000494477 | SCV000582546 | pathogenic | not provided | 2022-04-07 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect as the p.A934T variant causes a marked increase in KCNT1 protein function; the mutant channel activates significantly more quickly than wild-type channels with greater current amplitude (Barcia et al., 2012; Milligan et al., 2014; Kim et al., 2014); Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23599387, 26122718, 23086397, 25482562, 27620904, 26785903, 26441003, 26140313, 26740507, 27779742, 27064559, 29390993, 30182498, 31054490, 31487502, 30847371, 30782581, 31872048, 31532509, 32139178, 24591078, 29100083, 32167590) |
Baylor Genetics | RCV000032794 | SCV000807331 | pathogenic | Developmental and epileptic encephalopathy, 14 | 2023-03-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000494477 | SCV001247128 | pathogenic | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | KCNT1: PS2, PM1, PM2, PS4:Moderate, PS3:Supporting |
Kasturba Medical College, |
RCV000032794 | SCV001786703 | pathogenic | Developmental and epileptic encephalopathy, 14 | criteria provided, single submitter | clinical testing | ||
Revvity Omics, |
RCV000494477 | SCV002023233 | pathogenic | not provided | 2019-09-26 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000032794 | SCV000056562 | pathogenic | Developmental and epileptic encephalopathy, 14 | 2012-11-01 | no assertion criteria provided | literature only |